Cargando…
Challenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil: The PROVAR Study Experience
Autores principales: | dos Santos, Julia Pereira Afonso, do Carmo, Gabriel Assis Lopes, Beaton, Andrea Zawacki, Lourenço, Tainá Vitti, Diamantino, Adriana Costa, Nunes, Maria do Carmo Pereira, Sable, Craig, Nascimento, Bruno Ramos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421477/ https://www.ncbi.nlm.nih.gov/pubmed/28538764 http://dx.doi.org/10.5935/abc.20170047 |
Ejemplares similares
-
Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
por: Nascimento, Bruno R., et al.
Publicado: (2018) -
Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
por: Ubels, Jasper, et al.
Publicado: (2020) -
Bedside echocardiography to predict mortality of COVID-19 patients beyond clinical data: Data from the PROVAR-COVID study
por: Pimentel, Sander Luis Gomes, et al.
Publicado: (2021) -
Investigation of the Familial Risk of Rheumatic Heart Disease with Systematic Echocardiographic Screening: Data from the PROVAR+ Family Study †
por: Franco, Juliane, et al.
Publicado: (2022) -
FOCUSED ECHOCARDIOGRAPHY FOR REDEFINING THE PROGNOSIS OF PATIENTS HOSPITALIZED WITH COVID-19 BEYOND CLINICAL DATA - DATA FROM THE PROVAR-COVID STUDY
por: Nascimento, Bruno Ramos, et al.
Publicado: (2021)